Crestline Management LP bought a new stake in shares of Exponent, Inc. (NASDAQ:EXPO) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 27,840 shares of the business services provider’s stock, valued at approximately $1,979,000. Crestline Management LP owned about 0.11% of Exponent at the end of the most recent reporting period.
A number of other institutional investors also recently made changes to their positions in the business. Millennium Management LLC lifted its position in Exponent by 557.1% during the fourth quarter. Millennium Management LLC now owns 113,998 shares of the business services provider’s stock valued at $8,105,000 after purchasing an additional 96,650 shares during the last quarter. TIAA CREF Investment Management LLC lifted its position in Exponent by 30.5% during the fourth quarter. TIAA CREF Investment Management LLC now owns 113,802 shares of the business services provider’s stock valued at $8,091,000 after purchasing an additional 26,579 shares during the last quarter. Teachers Advisors LLC lifted its position in Exponent by 22.1% during the fourth quarter. Teachers Advisors LLC now owns 286,976 shares of the business services provider’s stock valued at $20,404,000 after purchasing an additional 51,980 shares during the last quarter. Raymond James & Associates lifted its position in Exponent by 8.5% during the fourth quarter. Raymond James & Associates now owns 28,376 shares of the business services provider’s stock valued at $2,018,000 after purchasing an additional 2,211 shares during the last quarter. Finally, HBK Investments L P bought a new stake in Exponent during the fourth quarter valued at approximately $434,000. Institutional investors and hedge funds own 88.91% of the company’s stock.
Several equities research analysts have issued reports on the stock. Zacks Investment Research upgraded shares of Exponent from a “hold” rating to a “buy” rating and set a $82.00 target price for the company in a research report on Tuesday, January 23rd. BidaskClub lowered shares of Exponent from a “hold” rating to a “sell” rating in a research report on Friday, December 15th. Finally, SunTrust Banks upgraded shares of Exponent from a “hold” rating to a “buy” rating and set a $84.00 target price for the company in a research report on Friday, January 26th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $84.67.
Exponent (NASDAQ:EXPO) last announced its quarterly earnings data on Thursday, February 1st. The business services provider reported $0.47 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.42 by $0.05. The firm had revenue of $82.72 million during the quarter, compared to analyst estimates of $80.27 million. Exponent had a net margin of 11.88% and a return on equity of 17.81%. The business’s quarterly revenue was up 13.7% on a year-over-year basis. During the same period in the previous year, the business posted $0.39 EPS. analysts expect that Exponent, Inc. will post 2.41 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 23rd. Stockholders of record on Friday, March 2nd will be issued a $0.26 dividend. This represents a $1.04 dividend on an annualized basis and a dividend yield of 1.31%. This is a positive change from Exponent’s previous quarterly dividend of $0.21. The ex-dividend date of this dividend is Thursday, March 1st. Exponent’s payout ratio is presently 68.42%.
ILLEGAL ACTIVITY NOTICE: This piece of content was originally reported by American Banking News and is the property of of American Banking News. If you are reading this piece of content on another domain, it was stolen and republished in violation of international trademark and copyright laws. The original version of this piece of content can be accessed at https://www.americanbankingnews.com/2018/03/14/crestline-management-lp-takes-position-in-exponent-inc-expo.html.
Exponent, Inc (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health.
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO).
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.